Cite

HARVARD Citation

    Tsoukas, C. et al. (2013). Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy. ISRN AIDS. p. . [Online]. 
  
Back to record